Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-driven hospital readmission predictor market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market covering 2026–2035?
The market size for artificial intelligence (AI)-driven hospital readmission predictors has experienced significant expansion over recent years. This sector is anticipated to increase from $1.92 billion in 2025 to $2.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 26.2%. The historical drivers for this growth include the escalating integration of AI in healthcare, the heightened necessity to minimize hospital readmissions, the increasing presence of electronic health records, the wider deployment of predictive analytics, and an enhanced emphasis on patient welfare.
The artificial intelligence (AI)-driven hospital readmission predictor market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $6.09 billion, demonstrating a compound annual growth rate (CAGR) of 25.9%. This anticipated growth throughout the forecast period stems from several factors, including increased investments in healthcare information technology infrastructure, greater incorporation of clinical decision support systems, wider uptake of cloud-based analytics platforms, the broadening availability of remote patient monitoring instruments, and a heightened focus on value-based care frameworks. Key developments expected during this timeframe encompass technological progress in machine learning models, breakthroughs in real-time patient observation, intensified research and development efforts in natural language processing, the emergence of explainable AI solutions tailored for healthcare, and enhancements in interoperable healthcare IT systems.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?
The expansion of the artificial intelligence (AI)-driven hospital readmission predictor market is anticipated to be driven by the rising occurrence of chronic diseases. These conditions are persistent health issues, like diabetes, heart disease, and arthritis, that typically advance gradually and necessitate continuous medical care and lifestyle adjustments to manage symptoms and avoid complications. Their growing frequency is primarily linked to unhealthy habits such as poor nutrition, lack of exercise, and smoking, which elevate the likelihood of developing conditions like diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic diseases by examining patient data to pinpoint individuals with a significant risk of readmission. These tools enhance patient results through proactive interventions, customized care plans, and prompt follow-ups, thereby preventing complications and shortening hospital admissions. As an illustration, the National Health Service, a UK-based government department, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) had received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, not yet meeting the criteria for diabetes) in 2023. This represented an 18% rise from the 3,065,825 cases observed in 2022. Consequently, the rising incidence of chronic diseases is fostering the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market.
What Leading Segments Are Studied In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?
The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud
3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools
2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices
3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services
What Trends Are Projected To Support The Growth Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?
Companies active in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on developing sophisticated solutions, such as advanced predictive modeling, to identify high-risk patients, facilitate proactive interventions, and improve post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques with historical and real-time data to uncover intricate patterns and generate highly precise forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution. This solution integrates advanced predictive modeling to pinpoint avoidable readmissions across Medicare, Medicaid, and uninsured populations. The platform also delivers unified 360-degree patient views, agentic AI tools including Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for strategic intervention planning. This solution empowers healthcare providers to lower readmission rates, optimize resource allocation, and improve overall patient outcomes.
Which Leading Companies Dominate The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Share?
Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx
Access The Complete Report For Deeper Market Insights:
How Does The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Perform Across Major Global Regions?
North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30521&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market 2026, By The Business Research Company
Artificial Intelligence In Healthcare Diagnosis Market Report 2026
Artificial Intelligence In Healthcare Market 2026
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market
generative ai in healthcare global market report
https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model